Assessment of a quality improvement intervention to decrease opioid prescribing in a regional health system.
clinical practice guidelines
continuous quality improvement
health policy
patient satisfaction
quality improvement
Journal
BMJ quality & safety
ISSN: 2044-5423
Titre abrégé: BMJ Qual Saf
Pays: England
ID NLM: 101546984
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
07
04
2020
revised:
15
08
2020
accepted:
24
08
2020
pubmed:
18
9
2020
medline:
16
10
2021
entrez:
17
9
2020
Statut:
ppublish
Résumé
Opioids are prescribed in excess after surgery. We leveraged our continuous quality improvement infrastructure to implement opioid prescribing guidelines and subsequently evaluate changes in postoperative opioid prescribing, consumption and patient satisfaction/pain in a statewide regional health system. We collected data regarding postoperative prescription size, opioid consumption and patient-reported outcomes from February 2017 to May 2019, from a 70-hospital surgical collaborative. Three iterations of prescribing guidelines were released. An interrupted time series analysis before and after each guideline release was performed. Linear regression was used to identify trends in consumption and patient-reported outcomes over time. We included 36 022 patients from 69 hospitals who underwent one of nine procedures in the guidelines, of which 15 174 (37.3%) had complete patient-reported outcomes data following surgery. Before the intervention, prescription size was decreasing over time (slope: -0.7 tablets of 5 mg oxycodone/month, 95% CI -1.0 to -0.5 tablets, p<0.001). After the first guideline release, prescription size declined by -1.4 tablets/month (95% CI -1.8 to -1.0 tablets, p<0.001). The difference between these slopes was significant (p=0.006). The second guideline release resulted in a relative increase in slope (-0.3 tablets/month, 95% CI -0.1 to -0.6, p<0.001). The third guideline release resulted in no change (p=0.563 for the intervention). Overall, mean (SD) prescription size decreased from 25 (17) tablets of 5 mg oxycodone to 12 (8) tablets. Opioid consumption also decreased from 11 (16) to 5 (7) tablets (p<0.001), while satisfaction and postoperative pain remained unchanged. The use of procedure-specific prescribing guidelines reduced statewide postoperative opioid prescribing by 50% while providing satisfactory pain care. These results demonstrate meaningful impact on opioid prescribing using evidence-based best practices and serve as an example of successful utilisation of a regional health collaborative for quality improvement.
Sections du résumé
BACKGROUND
Opioids are prescribed in excess after surgery. We leveraged our continuous quality improvement infrastructure to implement opioid prescribing guidelines and subsequently evaluate changes in postoperative opioid prescribing, consumption and patient satisfaction/pain in a statewide regional health system.
METHODS
We collected data regarding postoperative prescription size, opioid consumption and patient-reported outcomes from February 2017 to May 2019, from a 70-hospital surgical collaborative. Three iterations of prescribing guidelines were released. An interrupted time series analysis before and after each guideline release was performed. Linear regression was used to identify trends in consumption and patient-reported outcomes over time.
RESULTS
We included 36 022 patients from 69 hospitals who underwent one of nine procedures in the guidelines, of which 15 174 (37.3%) had complete patient-reported outcomes data following surgery. Before the intervention, prescription size was decreasing over time (slope: -0.7 tablets of 5 mg oxycodone/month, 95% CI -1.0 to -0.5 tablets, p<0.001). After the first guideline release, prescription size declined by -1.4 tablets/month (95% CI -1.8 to -1.0 tablets, p<0.001). The difference between these slopes was significant (p=0.006). The second guideline release resulted in a relative increase in slope (-0.3 tablets/month, 95% CI -0.1 to -0.6, p<0.001). The third guideline release resulted in no change (p=0.563 for the intervention). Overall, mean (SD) prescription size decreased from 25 (17) tablets of 5 mg oxycodone to 12 (8) tablets. Opioid consumption also decreased from 11 (16) to 5 (7) tablets (p<0.001), while satisfaction and postoperative pain remained unchanged.
CONCLUSIONS
The use of procedure-specific prescribing guidelines reduced statewide postoperative opioid prescribing by 50% while providing satisfactory pain care. These results demonstrate meaningful impact on opioid prescribing using evidence-based best practices and serve as an example of successful utilisation of a regional health collaborative for quality improvement.
Identifiants
pubmed: 32938775
pii: bmjqs-2020-011295
doi: 10.1136/bmjqs-2020-011295
pmc: PMC8056599
mid: NIHMS1655744
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Pagination
251-259Subventions
Organisme : NIDA NIH HHS
ID : F32 DA050416
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA042859
Pays : United States
Organisme : AHRQ HHS
ID : T32 HS000053
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Ann Surg. 2018 Mar;267(3):468-472
pubmed: 28267689
Ann Surg. 2019 Sep;270(3):452-462
pubmed: 31356279
JAMA. 2016 Apr 19;315(15):1654-7
pubmed: 26978756
Ann Surg Oncol. 2018 Jul;25(7):1843-1851
pubmed: 29637436
N Engl J Med. 2015 Jan 15;372(3):241-8
pubmed: 25587948
JAMA Surg. 2017 Nov 1;152(11):1066-1071
pubmed: 28768328
Clin J Pain. 2003 Sep-Oct;19(5):286-97
pubmed: 12966254
JAMA Psychiatry. 2014 Jul 1;71(7):821-6
pubmed: 24871348
J Hand Surg Am. 2016 Oct;41(10):947-957.e3
pubmed: 27692801
Ann Surg. 2020 Feb;271(2):290-295
pubmed: 30048311
J Am Coll Surg. 2018 Sep;227(3):374-381
pubmed: 30056059
Int J Epidemiol. 2017 Feb 1;46(1):348-355
pubmed: 27283160
J Am Coll Surg. 2018 Jun;226(6):996-1003
pubmed: 29198638
JAMA. 2015 Nov 3;314(17):1818-31
pubmed: 26529160
JAMA Surg. 2017 Jun 21;152(6):e170504
pubmed: 28403427
JAMA Surg. 2019 Jan 1;154(1):e184234
pubmed: 30422239
Ann Surg Oncol. 2019 Jan;26(1):17-24
pubmed: 30238243
J Clin Oncol. 2017 Dec 20;35(36):4042-4049
pubmed: 29048972
J Oral Maxillofac Surg. 2016 Jul;74(7):1291-3
pubmed: 27156949
MMWR Recomm Rep. 2016 Mar 18;65(1):1-49
pubmed: 26987082
Ann Surg. 2018 Mar;267(3):e46-e47
pubmed: 29215369
JAMA. 2011 Apr 6;305(13):1315-21
pubmed: 21467284
Ann Surg. 2018 Sep;268(3):457-468
pubmed: 30004924
JAMA Surg. 2017 Sep 1;152(9):860-867
pubmed: 28614551
Med Care. 2007 May;45(5 Suppl 1):S3-S11
pubmed: 17443116
JAMA Surg. 2018 Oct 1;153(10):948-954
pubmed: 30140931
Pediatrics. 2018 Jan;141(1):
pubmed: 29203521
J Am Coll Surg. 2018 Oct;227(4):411-418
pubmed: 30118896
N Engl J Med. 2019 Aug 15;381(7):680-682
pubmed: 31412184
Ann Surg. 2017 Apr;265(4):709-714
pubmed: 27631771
Ann Surg. 2020 Feb;271(2):266-278
pubmed: 31356268
Ann Surg. 2017 Apr;265(4):728-730
pubmed: 27429023
JAMA Surg. 2018 Mar 1;153(3):285-287
pubmed: 29214318